These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 18997817)
1. The uPA/uPAR system regulates the bioavailability of PDGF-DD: implications for tumour growth. Ehnman M; Li H; Fredriksson L; Pietras K; Eriksson U Oncogene; 2009 Jan; 28(4):534-44. PubMed ID: 18997817 [TBL] [Abstract][Full Text] [Related]
2. PDGF-D is a potent transforming and angiogenic growth factor. Li H; Fredriksson L; Li X; Eriksson U Oncogene; 2003 Mar; 22(10):1501-10. PubMed ID: 12629513 [TBL] [Abstract][Full Text] [Related]
3. Structural and functional specificities of PDGF-C and PDGF-D, the novel members of the platelet-derived growth factors family. Reigstad LJ; Varhaug JE; Lillehaug JR FEBS J; 2005 Nov; 272(22):5723-41. PubMed ID: 16279938 [TBL] [Abstract][Full Text] [Related]
4. Platelet-derived growth factor D is activated by urokinase plasminogen activator in prostate carcinoma cells. Ustach CV; Kim HR Mol Cell Biol; 2005 Jul; 25(14):6279-88. PubMed ID: 15988036 [TBL] [Abstract][Full Text] [Related]
5. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion. Hildenbrand R; Schaaf A Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473 [TBL] [Abstract][Full Text] [Related]
6. Tissue-type plasminogen activator is not necessary for platelet-derived growth factor-c activation. Riehle KJ; Johnson MM; Johansson F; Bauer RL; Hayes BJ; Gilbertson DG; Haran AC; Fausto N; Campbell JS Biochim Biophys Acta; 2014 Feb; 1842(2):318-25. PubMed ID: 24269585 [TBL] [Abstract][Full Text] [Related]
7. Platelet-derived growth factor-C (PDGF-C) activation by serine proteases: implications for breast cancer progression. Hurst NJ; Najy AJ; Ustach CV; Movilla L; Kim HR Biochem J; 2012 Feb; 441(3):909-18. PubMed ID: 22035541 [TBL] [Abstract][Full Text] [Related]
8. Urokinase plasminogen activator and urokinase plasminogen activator receptor mediate human stem cell tropism to malignant solid tumors. Gutova M; Najbauer J; Frank RT; Kendall SE; Gevorgyan A; Metz MZ; Guevorkian M; Edmiston M; Zhao D; Glackin CA; Kim SU; Aboody KS Stem Cells; 2008 Jun; 26(6):1406-13. PubMed ID: 18403751 [TBL] [Abstract][Full Text] [Related]
10. Urokinase-receptor-mediated phenotypic changes in vascular smooth muscle cells require the involvement of membrane rafts. Kiyan J; Smith G; Haller H; Dumler I Biochem J; 2009 Oct; 423(3):343-51. PubMed ID: 19691446 [TBL] [Abstract][Full Text] [Related]
11. The tyrosine phosphatase SHP-2 controls urokinase-dependent signaling and functions in human vascular smooth muscle cells. Kiyan J; Haller H; Dumler I Exp Cell Res; 2009 Apr; 315(6):1029-39. PubMed ID: 19133257 [TBL] [Abstract][Full Text] [Related]
12. The PDGF family: four gene products form five dimeric isoforms. Fredriksson L; Li H; Eriksson U Cytokine Growth Factor Rev; 2004 Aug; 15(4):197-204. PubMed ID: 15207811 [TBL] [Abstract][Full Text] [Related]
13. Differential proteome expression associated with urokinase plasminogen activator receptor (uPAR) suppression in malignant epithelial cancer. Saldanha RG; Xu N; Molloy MP; Veal DA; Baker MS J Proteome Res; 2008 Nov; 7(11):4792-806. PubMed ID: 18808175 [TBL] [Abstract][Full Text] [Related]
14. Tissue plasminogen activator is a potent activator of PDGF-CC. Fredriksson L; Li H; Fieber C; Li X; Eriksson U EMBO J; 2004 Oct; 23(19):3793-802. PubMed ID: 15372073 [TBL] [Abstract][Full Text] [Related]
15. PDGF-D activation by macrophage-derived uPA promotes AngII-induced cardiac remodeling in obese mice. Cheng YW; Zhang ZB; Lan BD; Lin JR; Chen XH; Kong LR; Xu L; Ruan CC; Gao PJ J Exp Med; 2021 Sep; 218(9):. PubMed ID: 34236404 [TBL] [Abstract][Full Text] [Related]
16. Ab initio molecular orbital calculations on specific interactions between urokinase-type plasminogen activator and its receptor. Nagase K; Kobayashi H; Yoshikawa E; Kurita N J Mol Graph Model; 2009 Aug; 28(1):46-53. PubMed ID: 19403319 [TBL] [Abstract][Full Text] [Related]
17. Urokinase-type plasminogen activator is a marker of aggressive phenotype and an independent prognostic factor in mismatch repair-proficient colorectal cancer. Minoo P; Baker K; Baumhoer D; Terracciano L; Lugli A; Zlobec I Hum Pathol; 2010 Jan; 41(1):70-8. PubMed ID: 19740518 [TBL] [Abstract][Full Text] [Related]
18. PDGF-C is a new protease-activated ligand for the PDGF alpha-receptor. Li X; Pontén A; Aase K; Karlsson L; Abramsson A; Uutela M; Bäckström G; Hellström M; Boström H; Li H; Soriano P; Betsholtz C; Heldin CH; Alitalo K; Ostman A; Eriksson U Nat Cell Biol; 2000 May; 2(5):302-9. PubMed ID: 10806482 [TBL] [Abstract][Full Text] [Related]
19. PDGF-C controls proliferation and is down-regulated by retinoic acid in mouse embryonic palatal mesenchymal cells. Han J; Xiao Y; Lin J; Li Y Birth Defects Res B Dev Reprod Toxicol; 2006 Oct; 77(5):438-44. PubMed ID: 17066417 [TBL] [Abstract][Full Text] [Related]
20. PDGF-C mediates the angiogenic and tumorigenic properties of fibroblasts associated with tumors refractory to anti-VEGF treatment. Crawford Y; Kasman I; Yu L; Zhong C; Wu X; Modrusan Z; Kaminker J; Ferrara N Cancer Cell; 2009 Jan; 15(1):21-34. PubMed ID: 19111878 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]